The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Brichta, L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg256 · Cited by 382
De Novo and Inherited Deletions of the 5q13 Region in Spinal Muscular Atrophies
Melki, J., Lefebvre, S., Burglen, L., Burlet, P., Clermont, O., Millasseau, P., Reboullet, S., Bénichou, B., Zeviani, M., Le Paslier, D., et al. (1994) · Science · doi:10.1126/science.7910982 · Cited by 322
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
Sumner, C. J., Huynh, T. N., Markowitz, J. A., Perhac, J. S., Hill, B., Coovert, D. D., Schussler, K., Chen, X., Jarecki, J., Burghes, A. H. M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10743 · Cited by 289
Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients
Brahe, C., Vitali, T., Tiziano, F. D., Angelozzi, C., Pinto, A. M., Borgo, F., Moscato, U., Bertini, E., Mercuri, E. M., & Neri, G. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201320 · Cited by 156
Pilot trial of phenylbutyrate in spinal muscular atrophy
Mercuri, E. M., Bertini, E., Messina, S., Pelliccioni, M., D’Amico, A., Colitto, F., Massimiliano Mirabella, A., Tiziano, F. D., Vitali, T., Angelozzi, C., et al. (2003) · Neuromuscular Disorders · doi:10.1016/j.nmd.2003.11.006 · Cited by 141
Reliability of 4 Outcome Measures in Pediatric Spinal Muscular Atrophy
Iannaccone, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1130 · Cited by 134
Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells
Grzeschik, S. M., Ganta, M., Prior, T. W., Heavlin, W. D., & Wang, C. H. (2005) · Annals of Neurology · doi:10.1002/ana.20548 · Cited by 113
Outcome Measures for Pediatric Spinal Muscular Atrophy
Iannaccone, S. T. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1445 · Cited by 98
Therapeutics development for spinal muscular atrophy
Sumner, C. J. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.010 · Cited by 97
Cited by
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710504 · Cited by 1,433
Self-citationCrooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.004 · Cited by 841
Results from a phase 1 study of nusinersen (ISIS-SMN Rx ) in children with spinal muscular atrophy
Chiriboga, C. A., Swoboda, K. J., Darras, B. T., Iannaccone, S. T., Montes, J., De Vivo, D. C., Norris, D. A., Bennett, C. F., & Bishop, K. M. (2016) · Neurology · doi:10.1212/wnl.0000000000002445 · Cited by 612
Self-citationChildhood spinal muscular atrophy: controversies and challenges
Mercuri, E., Bertini, E., & Iannaccone, S. T. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70061-3 · Cited by 423
Prospective cohort study of spinal muscular atrophy types 2 and 3
Kaufmann, P., McDermott, M. P., Darras, B. T., Finkel, R. S., Sproule, D. M., Kang, P. B., Oskoui, M., Constantinescu, A., Gooch, C. L., Foley, A. R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f7e4 · Cited by 283
Self-citation
Metadata
- Authors
- O’Hagen, J. M., Glanzman, A. M., McDermott, M. P., Ryan, P. A., Flickinger, J., Quigley, J., Riley, S., Sanborn, E., Irvine, C., Martens, W. B., Annis, C., Tawil, R., Oskoui, M., Darras, B. T., Finkel, R. S., & De Vivo, D. C.
- Venue
- Neuromuscular Disorders
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 17
- Issue
- 9-10
- Pages
- 693-697
- ISSN
- 0960-8966 (ISSN-L)
- OpenAlex
- W1963604250
- Cited by
- 380
- References
- 12
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. https://app.cochat.ai/papers/10.1016/j.nmd.2007.05.009
- The paper
- O’Hagen, J. M., Glanzman, A. M., McDermott, M. P., Ryan, P. A., Flickinger, J., Quigley, J., Riley, S., Sanborn, E., Irvine, C., Martens, W. B., Annis, C., Tawil, R., Oskoui, M., Darras, B. T., Finkel, R. S., & De Vivo, D. C. (2007). An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscular Disorders. https://doi.org/10.1016/j.nmd.2007.05.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.